Duality Advisers, LP Charles River Laboratories International, Inc. Transaction History

Duality Advisers, LP

  • $0
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023
BUY
$197.11 - $250.07 $1.11 Million - $1.41 Million
5,622 New
5,622 $1.22 Million
Q2 2022

Aug 08, 2022
BUY
$204.13 - $302.4 $1.57 Million - $2.33 Million
7,690 Added 129.92%
13,609 $2.91 Million
Q1 2022

May 09, 2022
BUY
$255.51 - $362.11 $102,970 - $145,930
403 Added 7.31%
5,919 $1.68 Million
Q4 2021

Feb 02, 2022
BUY
$351.38 - $448.68 $1.94 Million - $2.47 Million
5,516 New
5,516 $2.08 Million

Others Institutions Holding CRL

# of Institutions
698
Shares Held
52.3M
Call Options Held
259K
Put Options Held
463K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Duality Advisers, LP Portfolio

Follow Duality Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Duality Advisers, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email